AAAAAA
Results: 1-25/77
Authors:
FURST DE
Citation: De. Furst, PERSPECTIVES ON THE CYCLOOXYGENASE-2 CYCLOOXYGENASE-1 HYPOTHESIS/, Journal of clinical rheumatology, 4(5), 1998, pp. 40-48
Authors:
FURST DE
Citation: De. Furst, VASCULAR INVOLVEMENT IN SYSTEMIC-SCLEROSIS (SSC), Journal of vascular research, 35, 1998, pp. 44-44
Authors:
WALLIS WJ
FURST DE
STRAND V
KEYSTONE E
Citation: Wj. Wallis et al., BIOLOGIC AGENTS AND IMMUNOTHERAPY IN RHEUMATOID-ARTHRITIS - PROGRESS AND PERSPECTIVE, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 537
Authors:
FURST DE
Citation: De. Furst, CLINICAL-PHARMACOLOGY OF COMBINATION DISE ASE-CONTROLLING (DCART DMARD) THERAPY IN RHEUMATOID-ARTHRITIS/, Zeitschrift fur Rheumatologie, 57(1), 1998, pp. 20-24
Authors:
SEIBOLD JR
CLEMENTS PJ
FURST DE
MAYES MD
MCCLOSKEY DA
MORELAND LW
WHITE B
WIGLEY FM
ROCCO S
ERIKSON M
HANNIGAN JF
SANDERS ME
AMENTO EP
Citation: Jr. Seibold et al., SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(2), 1998, pp. 302-307
Authors:
CALDWELL JR
FURST DE
SMITH AL
CLARK JA
BONEBRAKE RA
GRUHN WB
MCILWAIN HH
LOGUE CM
Citation: Jr. Caldwell et al., FLARE DURING DRUG-WITHDRAWAL AS A METHOD TO SUPPORT EFFICACY IN RHEUMATOID-ARTHRITIS - AMIPRILOSE HYDROCHLORIDE AS AN EXAMPLE IN A DOUBLE-BLIND, RANDOMIZED STUDY, Journal of rheumatology, 25(1), 1998, pp. 30-35
Authors:
FURST DE
CLEMENTS PJ
STEEN VD
MEDSGER TA
MASI AT
DANGELO WA
LACHENBRUCH PA
GRAU RG
SEIBOLD JR
Citation: De. Furst et al., THE MODIFIED RODNAN SKIN SCORE IS AN ACCURATE REFLECTION OF SKIN BIOPSY THICKNESS IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(1), 1998, pp. 84-88
Authors:
NELSON JL
FURST DE
MALONEY S
GOOLEY T
EVANS PC
SMITH A
BEAN MA
OBER C
BIANCHI DW
Citation: Jl. Nelson et al., MICROCHIMERISM AND HLA-COMPATIBLE RELATIONSHIPS OF PREGNANCY IN SCLERODERMA, Lancet, 351(9102), 1998, pp. 559-562
Authors:
HUANG SC
JIANG R
HUFNAGLE WO
FURST DE
WILSKE KR
MILNER ECB
Citation: Sc. Huang et al., V-H USAGE AND SOMATIC HYPERMUTATION IN PERIPHERAL-BLOOD B-CELLS OF PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Clinical and experimental immunology, 112(3), 1998, pp. 516-527
Authors:
FURST DE
MCSWEENEY P
NELSON JL
NASH R
WENER M
SULLIVAN KM
Citation: De. Furst et al., INTENSIVE IMMUNOSUPPRESSION AND STEM-CELL TRANSPLANTATION (SCT) IN SCLERODERMA (SSC), Arthritis and rheumatism, 41(9), 1998, pp. 416-416
Authors:
FURST DE
FELSON D
GENDREAU M
Citation: De. Furst et al., PATIENTS WITH SEVERE RHEUMATOID-ARTHRITIS RESPONDING TO TREATMENT RESPOND AGAIN ON RETREATMENT, Arthritis and rheumatism, 41(9), 1998, pp. 1701-1701
Authors:
WIGLEY FM
KORN JH
CSUKA ME
MEDSGER TA
ROTHFIELD NF
ELLMAN M
MARTIN R
COLLIER DH
WEINSTEIN A
FURST DE
JIMENEZ SA
MAYES MD
MERKEL PA
GRUBER B
KAUFMAN L
VARGA J
BELL P
KERN J
MARROTT P
WHITE B
SIMMS RW
PHILLIPS AC
SEIBOLD JR
Citation: Fm. Wigley et al., ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY, Arthritis and rheumatism, 41(4), 1998, pp. 670-677
Authors:
VANGESTEL AM
HAAGSMA CJ
FURST DE
VANRIEL PLCM
Citation: Am. Vangestel et al., TREATMENT OF EARLY RHEUMATOID-ARTHRITIS PATIENTS WITH SLOW-ACTING ANTIRHEUMATIC DRUGS (SAARDS), Bailliere's clinical rheumatology, 11(1), 1997, pp. 65-82
Authors:
HILLSON JL
FURST DE
Citation: Jl. Hillson et De. Furst, PHARMACOLOGY AND PHARMACOKINETICS OF METHOTREXATE IN RHEUMATIC DISEASE - PRACTICAL ISSUES IN TREATMENT AND DESIGN, Rheumatic diseases clinics of North America, 23(4), 1997, pp. 757
Authors:
FURST DE
Citation: De. Furst, FROM DISEASE MODIFICATION TO DISEASE-CONTROL IN RHEUMATOID-ARTHRITIS, Clinical and experimental rheumatology, 15(3), 1997, pp. 63-66
Authors:
SULLIVAN KM
FURST DE
Citation: Km. Sullivan et De. Furst, THE EVOLVING ROLE OF BLOOD AND MARROW TRANSPLANTATION FOR THE TREATMENT OF AUTOIMMUNE-DISEASES, Journal of rheumatology, 24, 1997, pp. 1-4
Authors:
FURST DE
CLEMENTS PJ
Citation: De. Furst et Pj. Clements, HYPOTHESIS FOR THE PATHOGENESIS OF SYSTEMIC-SCLEROSIS, Journal of rheumatology, 24, 1997, pp. 53-57
Authors:
NASH RA
MCSWEENEY PA
STORB R
NELSON JL
GAUTHIER J
FURST DE
SULLIVAN KM
Citation: Ra. Nash et al., DEVELOPMENT OF A PROTOCOL FOR ALLOGENEIC MARROW TRANSPLANTATION FOR SEVERE SYSTEMIC-SCLEROSIS - PARADIGM FOR AUTOIMMUNE-DISEASE, Journal of rheumatology, 24, 1997, pp. 72-78
Authors:
MCSWEENEY PA
NASH RA
STORB R
FURST DE
GAUTHIER J
SULLIVAN KM
Citation: Pa. Mcsweeney et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASES - ISSUESIN PROTOCOL DEVELOPMENT, Journal of rheumatology, 24, 1997, pp. 79-84
Authors:
CLEMENTS PJ
FURST DE
Citation: Pj. Clements et De. Furst, CHOOSING APPROPRIATE PATIENTS WITH SYSTEMIC-SCLEROSIS FOR TREATMENT BY AUTOLOGOUS STEM-CELL TRANSPLANTATION, Journal of rheumatology, 24, 1997, pp. 85-88
Authors:
FURST DE
Citation: De. Furst, THE RATIONAL USE OF METHOTREXATE IN RHEUMATOID-ARTHRITIS AND OTHER RHEUMATIC DISEASES, British journal of rheumatology, 36(11), 1997, pp. 1196-1204
Authors:
FURST DE
Citation: De. Furst, MELOXICAM - SELECTIVE COX-2 INHIBITION IN CLINICAL-PRACTICE, Seminars in arthritis and rheumatism, 26(6), 1997, pp. 21-27
Authors:
MARTIN SW
FURST DE
KLAPPERICH R
SHEN DD
Citation: Sw. Martin et al., KINETICS OF HYDROXYCHLOROQUINE (HCQ) DURING HIGH-DOSE THERAPY IN RHEUMATOID-ARTHRITIS (RA), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 94-94
Authors:
FURST DE
Citation: De. Furst, HI-DOSE HYDROXYCHLOROQUINE (HCQ) IN RA - RESULTS OF A 6 WEEK DOSE-LOADING, DOUBLE-BLIND (DB) CONTROLLED-STUDY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 96-96
Authors:
FURST DE
MARTIN S
Citation: De. Furst et S. Martin, HI-DOSE HYDROXYCHLOROQUINE (HCQ) IN RHEUMATOID-ARTHRITIS (RA) - RESULTS OF A 6-WEEK, PHARMACOKINETIC (PK) DOSE-LOADING, DOUBLE-BLIND (DB) CONTROLLED-STUDY WITH AN 18-WEEK EXTENSION, Arthritis and rheumatism, 40(9), 1997, pp. 123-123